chrisvoncsefalvay/vaers-outcomes huggingface dataset:
low grade fever after 2nd dose; intense headache after 2nd dose; lost sense of smell and taste; raspy voice; loss of taste; mild fever; headache; congestion; This spontaneous case was reported by an other health care professional and describes the occurrence of NASAL CONGESTION (congestion), ANOSMIA (lost sense of smell and taste), DYSPHONIA (raspy voice), AGEUSIA (loss of taste) and PYREXIA (mild fever) in a 48-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 027L20A and 037K20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Diabetes. Concomitant products included INSULIN for Diabetes.   On 24-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Jan-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 30-Jul-2021, the patient experienced NASAL CONGESTION (congestion), PYREXIA (mild fever) and HEADACHE (headache). On 01-Aug-2021, the patient experienced ANOSMIA (lost sense of smell and taste), DYSPHONIA (raspy voice) and AGEUSIA (loss of taste). On an unknown date, the patient experienced PYREXIA (low grade fever after 2nd dose) and HEADACHE (intense headache after 2nd dose). At the time of the report, NASAL CONGESTION (congestion), ANOSMIA (lost sense of smell and taste), DYSPHONIA (raspy voice), AGEUSIA (loss of taste), PYREXIA (mild fever) and HEADACHE (headache) had not resolved and PYREXIA (low grade fever after 2nd dose) and HEADACHE (intense headache after 2nd dose) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 31-Jul-2021, SARS-CoV-2 test: positive (Positive) Positive.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment information not provided by the reporter. Reporter stated she wanted to report she tested positive for COVID19 on 31Jul2021 and said as a healthcare provider herself her thought is "duration of effect, it has been 7-8 months now" "different strains".   This case was linked to MOD-2021-275074 (E2B Linked Report).; Sender's Comments:  MOD-2021-275074:dose 1
pt recv vax 2FEB96 & devel fever & flu-like sx;pt recovered;addtl info recv 21MAR96 indicated pt remains recovered;
The adverse event is still taking place I?m currently still looking into treatment from the reaction my body is having.
Full body aches; Pain in opposite shoulder of injection; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Full body aches) and ARTHRALGIA (Pain in opposite shoulder of injection) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Thyroid disorder.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PAIN (Full body aches) and ARTHRALGIA (Pain in opposite shoulder of injection). At the time of the report, PAIN (Full body aches) and ARTHRALGIA (Pain in opposite shoulder of injection) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant products included thyroid medication daily.  Treatment information was not provided.   Most recent FOLLOW-UP information incorporated above includes: On 30-Jul-2021: Follow-up received on 31-jul-2021 contains updated event outcome of both the events from Unknown to Resolved.
Information has been received from a registered nurse concerning a 63-year-old female with a penicillin, aspirin and NSAIDS allergy as well as an allergy to insect/bee stings who on 06-SEP-2007 at 10:00 hours was vaccinated subcutaneous in the right arm with a 0.5 ml dose of Zostavax(Lot # 657764/0584U). There were no illnesses at the time of vaccination. Concomitant vaccines included DTaP administered on 06-SEP-2007 in the right arm and influenza virus vaccine (unspecified) administered on 27-SEP-2007. It was reported the patient developed a "welt" at the injection site after vaccination. The patient reported the event during a doctors appointment on 27-SEP-2007. The nurse stated that there was no welt seen on that appointment. She also reported that it was not clear whether the patient has a history of chicken pox. No diagnostic labs were performed. On an unspecified date the patient recovered. A product quality complaint was not involved. Additional information is not expected.
Swelling of feet and hands with itching skin. Desquamation of plantar area.
Clammy / Headache / numbness and tingling in left arm which resolved 1.5 hrs after receiving H1N1 inactivated injection of 5cc IM in left deltoid.
Vaccine exposure during pregnancy; This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of EXPOSURE DURING PREGNANCY (Vaccine exposure during pregnancy) in a 33-year-old female patient (gravida 1) who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012M20A) for COVID-19 vaccination.     Concomitant products included MINERALS NOS, VITAMINS NOS (PRENATAL VITAMINS [MINERALS NOS;VITAMINS NOS]) for an unknown indication.    On 13-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. The patient's last menstrual period was on 21-Oct-2020 and the estimated date of delivery was date. On 13-Feb-2021, the patient experienced EXPOSURE DURING PREGNANCY (Vaccine exposure during pregnancy). The patient received mRNA-1273 (Moderna COVID-19 Vaccine) beginning around the  sixteenth week of the pregnancy.  At the time of the report, EXPOSURE DURING PREGNANCY (Vaccine exposure during pregnancy) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Probably not related, but I did come down with a cold about 2-3 days after the shot; just thought I'd let you know.
First symptom was very painful injection site. Within about 6 hours I had a terrible headache and within 12 hours felt achy, low grade fever which lasted the entire next day.
vaccine given 6 days post expiry; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (vaccine given 6 days post expiry) in a 44-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 046C21A) for COVID-19 vaccination.     No Medical History information was reported.   On 15-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Nov-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 12-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (vaccine given 6 days post expiry). On 12-Nov-2021, EXPIRED PRODUCT ADMINISTERED (vaccine given 6 days post expiry) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication was reported. No treatment medication was reported.
Vomiting, low grade fever, loss of appetite. Intermittent vomiting lasted five hours (three episodes between 3am and 8am), fever resolved in 24 hours, low appetite lasted three days.
Child seen 1/17/14 and received Varicella vaccine (L) thigh. Developed warm, red, indurated injection site yesterday. Today cellulitis noted 3 x 1.5 cm on thigh.
1-17-07 pc from mom pt started with discomfort, headache 4 days and (1-12-07) 3 days palpable not occipital bone meaty transverse growth. Has enlarged painful to touch, pain radiates down backside right arm. No other symptoms. 1/18/07 10:45 am pc talked to mom-improving knot resolving, less painful, no headache, no pain radiating down right arm, feeling much better, per pt in background.  1/14/07 pc spoke with mom, everything basically back to normal. 1/22/07 and 1/26/07 made numerous pc left messages no return calls.
This spontaneous report as received from a physician refers to an unspecified number of patients. On unknown date an unspecified number of patients were administered with doses of GARDASIL (lot#, strength, dose, frequency, route unknown) that were improperly stored. No adverse effects were reported. The outcome of the event was unknown. This is one of several reports received from the same source. Additional information has been requested.
Patient received the Moderna vaccine on 03/18/21 and 04/16/21. COVID positive on 1/12/22. Presented to ER on 1/12/22 for the evaluation of a weakness and speech difficulty.  Patient reports he noticed left hand weakness yesterday around 4:00 p.m but as per wife patient had weakness from today morning.  Patient was not able to get out of his recliner as usual using his arms. Found to be incidentally COVID19 positive. Received sotrovimab infusion. Admitted for Stroke, not COVID19. Discharged on 1/16/22
pt recvd vax 25FEB76 & on 30AUG90 & lab eval revealed a low rubeola titer of .25 on 19MAY93; No further details were provided;
adverse events: headache, general body ache, unable to sleep due to pain treatments: advil capsules, relaxation, lying down Outcome: all pain resolved after 24 hours.
Patient approached observation desk, ambulatory, steady gait, alert and clear speech, stating: "I feel light headed." Patient assisted to chair. V/S assessed. BP125/73 T98.3 P112 RR22 SPO2 90% on room air. Skin is warm and dry to touch. No shortness of breath noted. Patient has had no change in level in level of consciousness. Will monitor for additional 15 minutes.  10:40AM Patient remains alert. PERRLA noted. Skin warm and dry to touch. Denies pain. Patient states: "I'm ok., I think it was anxiety." Patient refused snack that was offered. She also refused water stating "No, I'm ok." Patient walked out of facility. No distress. Alert, steady gait noted. V/S assessed at 1038 V/S BP108/68 P80 T98.4 R18 SPO2 99% on room air. Encouraged to notify doctor if she had further issues. She voiced understanding.
Mother telephoned health department about 2:30PM 1/14/04. Stated child had a fever of 102 and red rash on his stomach since this morning. Not brought down with Tylenol. Told her to use Ibuprofen according to dosage sheet for weight of child. Bathe and if fever and rash persistent to check with her family's physician. This was first set of immunizations for child. Breathing. 1/16/04 telephone call to mother, she took him to ER room visit; was told child had flu and she states he was given antibiotics and is ok today.
Patient experienced fever, diarrhea and fatigue the day following vaccine. Due to condition of fatigue, SOB, weight loss, and malaise not improving - patient saw primary care provider at 6 weeks. Patient has since been referred to a hematologist-oncologist to follow up with blood work of abnormal values. This provider instructed patient to report incident of adverse events.
Since receiving the Booster shot in January of 2022, I have experienced annoying, loud, ringing in my ears. It is unbearable if the room is quiet. It has affected my sleep. It is becoming life altering.  My doctor brushed it off, so I am in the process of obtaining a new doctor. This has kept me up at night. I have to muffle the sound with "white noise" of a fan or television. I have cried myself to sleep and paced the floor, put rubbing alcohol in my ears thinking it was wax build up. It is deafening, and affects my hearing acuity. I will go have a new hearing test, because I am not hearing properly anymore. I am a Speech Pathologist, and I NEED my hearing to treat people. If the vaccine caused this, I will never forgive my work for bullying me into getting it.  I am seeking legal counsel regarding this injury.
PATIENT WAS ADMINISTERED THE MODERNA VACCINE AND ABOUT 5 MINUTES LATER PATIENT COMPLAINED THAT SHE WAS FEELING VERY DIZZY, EMOTIONAL AND FEELING LIKE SHE WILL PASS OUT.  PATIENT PASSED OUT BRIEFLY (ABOUT 5 SECONDS) AND THEN CAME OUT OF IT.  PATIENT WAS NERVOUS AND ANXIOUS BEFORE INJECTING VACCINE AND SAID SHE WAS FEELING NERVOUS AND ANXIOUS ALL DAY LEADING UP TO GETTING THE VACCINE.  PATIENT PROBABLY EXPIERENCED SYNCOPE/DIZZINESS, WE GAVE HER WATER AND A CANDY BAR AND RECOMMEND SHE LAY DOWN BUT SHE REFUSED AND STAYED SITTING IN A CHAIR AND SHE WAS FEELING FINE.  AFTER PATIENT FELT BETTER , WE TOOK HER BLOOD PRESSURE AND PULSE, BP=118/72 AND PULSE= 72, WITHIN NORMAL LIMITS.  PATIENT WAS ASKED ABOUT CALLLING AMBULANCE BUT REFUSED.  AFTER 30 MINUTES OF SITTING SINCE EPISODE, SHE FELT BETTER AND SHE WENT HOME WITH PERSON SHE WAS WITH.
Wide area redness in the arm with very hot feel to it. Also pain in the arm with high sensitivity to the touch.
This case was reported by a healthcare professional, via a sales representative, and described the occurrence of bursitis in a subject of unspecified age and gender who was vaccinated with FLUARIX (GlaxoSmithKline). On an unspecified date the subject received a dose of FLUARIX (unknown details). At an unspecified time after vaccination with FLUARIX, the subject experienced bursitis, injection site reaction and joint inflammation. The subject developed "bursitis at the vaccination site and the inflammation spread to joints". At the time of reporting the outcome of the events was unspecified. The healthcare professional reported eight patients, all of which received the same lot number of FLUARIX (unspecified lot number), developed bursitis at the vaccination site and inflammation spread to joints. This is two of eight. See A0956566A, A0956568A, A0956569A, A0956570A, A0956571A, A0956572A and A0956573A for details regarding the additional cases.
Swelling, pain, redness. BENADRYL, hydrocortisone.
8 days later solid pink bumpy rash showed up and eventually spread over upper arm. Today, arm aches and feels tingly and heavy and a little weak (4/19/21)
Flu vaccine given twice within 10 minutes. Mom came with patient to my station.  I asked if patient needed a flu shot and if she had flu shot in the past.  Her mom replied yes to both. Vaccine was given. Nurse that gave first shot asked why I had given her another one.  The nurse said she came to me for a certificate of flu shot for school. Mother is not from here and I do not think she understood my question when she said yes. There was not reaction then and I followed up the following day with mother. The patient was fine without any reactions from shot.
10/22/19 Employee reported having a rash at site of injection with pruritis. 4 small circular  2-4cm  rash, flat,
I began my menses for the second time for the month of December which is not normal for me and it lasted 20 days. It continued to last 20 days every month for three months until I was finally seen by my OBGYN Dr. and my thyroid and labs were ok, my pelvic physical exam was also okay and my ultrasound of my pelvis was okay. I was started back on birth control to control the bleeding and the next month it only lasted 3 days as it normally did before the vaccines for COVID. I received the fist Pfizer dose at 8pm around the start of my night shift and when I awoke during the day around 2pm was found to have started my menses for the second time that month. I was also breastfeeding my baby still so have wondered how this effected her.  I also begin to have pain around my left chest when breathing and went to the ER in hospital probably within a month of completing the vaccines. My D-dimer was elevated so I was sent for a CT of the chest but they didn't find any PE's.
lump on my collar bone on the same side that the shot was given; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A patient (no qualifiers provided) received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (DOSE: 1), for COVID-19 Immunization. The following information was reported: CYST (non-serious), outcome "unknown", described as "lump on my collar bone on the same side that the shot was given".  Additional Information: After taking the second shot, two days after taking the second shot, patient started getting a lump, a big lump on my collar bone on the same side that the shot was given.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Experienced pressure in right ear, similar to tinnitus where there was ringing in my ears. Lymph nodes were also firing off
On 5SEP91, pt slept longer than usual & when awakened, ate poorly; immediately had projectile vomiting & old shunt site bulged; Foster mom decided to take pt to hosp; eyes rolled back & one side rt side of mouth drooped;
L axillary lymphadenopathy 4 days after receiving vaccine. No other causes of LA could be found. Recent Mammogram negative
3 hours after the vaccine, pt was resting on the couch watching tv. Pt stood up to go to the bathroom and almost collapsed. Realized she was unable to move her right leg. Ibuprofen was given and pt was put to bed alternating ice and heat packs to the affected area. Even after Motrin, pt still continues to cry out in pain and will not move right leg or let anyone touch it. By evening time, there was visible swelling to the leg all the way down to the toes. She was medicated with Tylenol, leg elevated on pillow and put to bed for the night. At midnight pt was screaming from pain. She is unable to bear weight, get up, or walk. She needs assistance to get dressed, go to the bathroom, and all other daily activities. This is day 2 and pt is still immobile and 10/10 pain. PCP was contacted first thing in am and he say ?this can happen, it?s not dangerous, just increase pain medicine?.
Patient received the vaccination and was speaking about bed sores for a few minutes after vaccine injection. I asked her to come back to waiting room to wait 15 minutes after vaccination. As we were walking back to waiting room, she stated she felt dizzy and light-headed. I asked if she had eaten anything today and she stated she had not. She asked me for a Sprite and I offered her some crackers. She sat in the waiting room until 3:16 PM. At that time she stated she felt much better and well enough to go home. I called her later that day in the 6 o'clock hour and she stated she had felt fine since.
This spontaneous report was received from a registered nurse regarding a patient of unknown age and gender. The patient's medical history, concomitant medication and drug reactions/allergies were not provided. On 19-APR-2012, the patient was vaccinated with an unidentified Merck HPV vaccine, lot # reported as V1229AA (which was not valid for GARDASIL or GARDASIL 9) for prophylaxis (frequency, route, anatomical location and expiration date were not provided) at the age of 14 years. Then, on 11-OCT-2013, the patient was vaccinated with an unidentified Merck HPV vaccine, lot # reported as VH021608 (which was not valid for GARDASIL or GARDASIL 9) for prophylaxis (frequency, route, anatomical location and expiration date were not provided) at the age of 15 years. Later, on 07-AUG-2015, the patient was vaccinated with an unidentified Merck HPV vaccine, lot # reported as VK026246 (which was not valid for GARDASIL or GARDASIL 9) for prophylaxis (frequency, route, anatomical location and expiration date were not provided) at the age of 17 years. Additionally, on 31-JUL-2017, at the age of 19 years, the patient received first dose of GARDASIL 9 injection, intramuscularly, lot # N004798, expiration date 31-OCT-2019 for prophylaxis (frequency and anatomical location were not provided). On 24-OCT-2017, the patient received second dose of GARDASIL 9 injection, intramuscularly, lot # N017832, expiration date 16-NOV-2019 for prophylaxis (frequency and anatomical location were not provided). No adverse effects were reported.
7yo patient received Boostrix; This case was reported by a nurse via call center representative and described the occurrence of inappropriate age at vaccine administration in a 7-year-old patient who received DTPa (Reduced antigen) (Boostrix) (batch number 229AN, expiry date 5th July 2022) for prophylaxis.   Previously administered products included Infanrix (received their first 4 doses when they were younger).   On an unknown date, the patient received Boostrix. On an unknown date, unknown after receiving Boostrix, the patient experienced inappropriate age at vaccine administration. On an unknown date, the outcome of the inappropriate age at vaccine administration was unknown.  Additional details were provided as follows: The registered nurse reported that 7 year old patient received Boostrix a couple months prior to the reporting as their 5th dose which led to inappropriate age at vaccine administration.   No patient details or date of administration was available for Infanrix doses.  The reporter consented to follow up.
Shingrix series in September of 2020 and then received dose two in August of 2022; This case was reported by a pharmacist via call center representative and described the occurrence of drug dose administration interval too long in a patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (1st dose received on September 2020).   In August 2022, the patient received the 2nd dose of Shingrix. In August 2022, unknown after receiving Shingrix, the patient experienced drug dose administration interval too long. On an unknown date, the outcome of the drug dose administration interval too long was unknown.      Additional Information: GSK receipt date: 30-NOV--2022 Reporters comment:  The pharmacist was in a rush to end the call and did not provide further details, but he did grant permission for safety to follow up if needed. The reporter consented to follow-up. Additional Supportive information: The patient received 2nd dose later than the recommended interval, which led to lengthening of vaccination schedule.
It was reported post 2nd vaccine pt experienced flu like symptoms, headachy,weak and left arm ached from the shoulder to hand.
Mom stated patients legs, hands, face and throat started swelling. She gave her a 1/2 of BENADRYL that night and she did good with. She was advised to continue the BENADRYL every 6 hrs for 24 hours, and take her to ER with any signs of troubles breathing.
EXTREMELY HUNGRY; FEVER; This spontaneous report received from a patient concerned a patient of unspecified age and sex. The patient's height, and weight were not reported. The patient's pre-existing medical conditions included whenever the patient gets sick or had a fever, experiences loss of appetite.  The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, and batch number: Unknown) dose was not reported, administered on 10-APR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported.  On 10-APR-2021, the subject experienced extremely hungry. On 10-APR-2021, the subject experienced fever. Treatment medications included: paracetamol. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from fever on 10-APR-2021, and the outcome of extremely hungry was not reported. This report was non-serious.
Patient called pharmacy on 9/25/13 to report that she had a rash from the zoster vaccine injection that has lasted for 6 days. She further stated that she experienced itching at the injection site for 1.5 days and then the rash developed sometime after. She reports that she did not noticed when it appeared. The patient's PCP was notified of the adverse reaction on 9/25/13.
Hives - swelling of throat. Tight chest pt left clinic after receiving vaccine and at 7p started having hives seen in ER about 2 AM and after treatment discharged home - 3/8/12 3:30p pt c/o swelling throat - tight chest seen by PCP - transported to hosp.